000			02026 a2200541 4500
005			20250513200327.0
264		0	_c20000113
008			200001s 0 0 eng d
022			_a0268-1161
024	7		_a10.1093/humrep/14.12.3080 _2doi
040			_aNLM _beng _cNLM
100	1		_aMacpherson, A M
245	0	0	_aThe effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium. _h[electronic resource]
260			_bHuman reproduction (Oxford, England) _cDec 1999
300			_a3080-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aCell Count _xdrug effects
650	0	4	_aContraceptive Agents, Female _xpharmacology
650	0	4	_aContraceptives, Oral, Combined _xpharmacology
650	0	4	_aDesogestrel _xpharmacology
650	0	4	_aDrug Combinations
650	0	4	_aEndometrium _xcytology
650	0	4	_aEndothelial Growth Factors _xantagonists & inhibitors
650	0	4	_aEndothelium _xcytology
650	0	4	_aEthinyl Estradiol _xpharmacology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aLymphokines _xantagonists & inhibitors
650	0	4	_aMenstrual Cycle _xphysiology
650	0	4	_aMenstruation _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aReceptors, Progesterone _xmetabolism
650	0	4	_aReference Values
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
650	0	4	_aVinyl Compounds _xadministration & dosage
700	1		_aArcher, D F
700	1		_aLeslie, S
700	1		_aCharnock-Jones, D S
700	1		_aMakkink, W K
700	1		_aSmith, S K
773	0		_tHuman reproduction (Oxford, England) _gvol. 14 _gno. 12 _gp. 3080-7
856	4	0	_uhttps://doi.org/10.1093/humrep/14.12.3080 _zAvailable from publisher's website
999			_c10557170 _d10557170